IDH1 and glioblastoma: Previous studies of GBM using single omics have pinpointed molecular anomalies such as IDH1, TP53, PTEN, EGFR, and PIK3CA, impacting tumour progression and survival prognosis.31, 32, 93, 94, 95, 96